Literature DB >> 2998840

Reversion of bovine papillomavirus-induced transformation and immortalization by a xanthate compound.

E Amtmann, K Müller, A Knapp, G Sauer.   

Abstract

Bovine papilloma virus-transformed hamster embryo fibroblasts (HEF-BPV) reacted to exposure to tricyclodecan-9-yl-xanthogenate (D609) with immediate reversion to the growth kinetics and the flat morphology of the untransformed parental cells. After six population doublings in the presence of D609, clones which displayed an untransformed morphology in the absence of D609 arose with a high frequency (90%). Such clones had reacquired a limited in vitro lifetime and had lost the ability to induce tumors in athymic nude mice. At the molecular level the revertant clones had lost all extrachromosomal monomeric BPV-1 DNA molecules. Only high molecular weight (HMW) oligomeric BPV-1 DNA that was probably integrated into the cellular genome was still detectable in a methylated transcriptionally inactive state. In contrast to transformed cells, the revertant clones no longer transcribed BPV-1-specific mRNA molecules, but were stimulated by a tumor promoter to transient viral gene expression. This article provides direct evidence for the complete reversibility of the property of "immortality".

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998840     DOI: 10.1016/0014-4827(85)90109-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

1.  Inhibition of c-fos transcription and phosphorylation of the serum response factor by an inhibitor of phospholipase C-type reactions.

Authors:  G Schalasta; C Doppler
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

2.  Phenotypic transformation of primary mouse fibroblasts by BPV 1 DNA.

Authors:  R Mäntyjärvi; H Sarkkinen; S Parkkinen; A Ryhänen; H Karjalainen; K Syrjänen; S Syrjänen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Bovine papillomavirus mutant temperature sensitive for transformation, replication and transactivation.

Authors:  D DiMaio; J Settleman
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.